Answers are grounded in this paper and cite their sources.
Research demonstrates potential neuroimaging epicenters in parkinson's disease, highlighting their clinical relevance.
Motivation: Parkinson's disease (PD) is highly heterogeneous and lacks a clear definition of its neuropathological mechanisms, complicating the identification of its origins and progression. Goal(s): This study aimed to identify neuroimaging epicenters in PD and evaluate their clinical significance. Approach: We employed a network-theory approach, known as epicenter mapping, on cross-sectional multimodal MRI to identify the most likely sources of structural pathology in PD. Results: Our results indicate that multiple nuclei in the midbrain, basal ganglia, and various cortical areas of the cerebellum may serve as neuroimaging epicenters in PD, with these features closely associated with patients' clinical symptoms. Impact: We developed a reliable method for identifying the epicenter using multimodal MRI, offering new insights for exploring the disease's potential sites and their clinical relevance in PD.
No takes yet. Share an insight, caveat, or question.
Duanmu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: